News |

NCIRS releases new and updated FAQs resources

As the weather cools across Australia and new vaccines and treatments become available, NCIRS has published a suite of FAQs resources on three of the most common respiratory diseases in Australia: influenza, COVID-19 and respiratory syncytial virus (RSV).

Authored by NCIRS specialists and designed to support both immunisation providers and the general public, the resources are based on the latest expert research and Australian Technical Advisory Group on Immunisation (ATAGI) advice.

Access the FAQs:

Influenza

COVID-19

RSV



News & events

News |

New study finds changes to herpes zoster vaccination in Australia have contributed to a decline in cases

News |

Why are more Australian parents taking childhood influenza vaccination off the priority list?
News |

‘Tens of thousands of young children unprotected’ as immunisation coverage hits five-year low in Australia
News |

One year on: hundreds of thousands of babies protected against RSV thanks to prevention product funding
News |

2026 influenza vaccine changes: ATAGI advice and NCIRS resources
News |

New SKAI resource supports provider–parent conversations about HPV vaccination as school immunisation programs commence
News |

National survey shows declining vaccine confidence among parents
News |

Whooping cough cases are at their highest level in 35 years – so why the surge?
News |

Implementation plan released for National Immunisation Strategy
News |

Bridging the vaccine introduction gap in Asia’s middle‑income countries
All news & events